Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

We aimed to examine the sex differences in the relation between vitamin D status, PA levels, obesity and sarcopenia in community-dwelling middle-aged and older adults, as well as whether vitamin D status is a modifier in the relationship between PA and sarcopenia.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Sex differences in the association of physical activity levels and vitamin D with obesity, sarcopenia, and sarcopenic obesity: a cross-sectional study

Source: Article title.

A total of 3713 participants aged ≥ 50y were included in our study.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Sex differences in the association of physical activity levels and vitamin D with obesity, sarcopenia, and sarcopenic obesity: a cross-sectional study

Cross-sectional study · BMC Geriatrics · 2022

Original publication title

Sex differences in the association of physical activity levels and vitamin D with obesity, sarcopenia, and sarcopenic obesity: a cross-sectional study

Shuli Jia; Wanyu Zhao; Fengjuan Hu; Yunli Zhao; Meiling Ge; Xin Xia; Jirong Yue; Birong Dong

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The role of vitamin D and PA in sarcopenia was different between men and women, and the relationship between PA and sarcopenia modified by serum vitamin D status. These findings highlighted the need to supplement vitamin D in individuals with physical inactivity and provide different interventions strategies to sarcopenia in men and women.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Sarcopenia is an age-related skeletal muscle disorder defined as accelerated loss of muscle mass and function [1]. Sarcopenia is associated with multiple adverse outcomes such as falls, physical disability, frailty and premature death [1]. In parallel with the development of sarcopenia, the prevalence of obesity is also rising with aging [2]. The concurrent presence of both sarcopenia and obesity in the same individual is defined as sarcopenic obesity (SO), which is a better predictor of negative health outcomes in older than sarcopenia or obesity alone [2, 3].

Physical inactivity and vitamin D deficiency often co-exist in older adults, and they are both risk factors for sarcopenia and obesity [1, 4, 5]. Previous studies have reported the role of vitamin D in the development of sarcopenia [6]. Serum levels of vitamin D are independently related to the loss of muscle mass and strength [7], particular in men [8]. Vitamin D deficiency is frequently observed in obese [9].

Evidence from observational studies suggests that obesity is associated with low vitamin D status as a result of the inverse between serum 25(OH)D concentration and body fat mass [10]. To our knowledge, studies related to the associations of physical activity levels, vitamin D, and sarcopenic obesity are limited. There are differences in physical activity levels and vitamin D between males and females. Vitamin D deficiency or physical inactivity as risk factor for sarcopenia may not be equally important in men and women.

Sex differences were often reported in the relationship between vitamin D and sarcopenia [11, 12], or in the effect of vitamin D supplementation on sarcopenia [13].

Physical inactivity and vitamin D deficiency may have synergistic effects on muscle degradation and exacerbate sarcopenia [14]. A previous study explored the interactive effect of vitamin D and physical activity on muscle mass and function through animal experiments and population surveys [14]. They concluded that the effect of vitamin D on sarcopenia depends on the level of physical activity in older adults [14]. Specifically, physical activity levels modified the relationship of vitamin D and sarcopenia.

At present, the treatment of sarcopenia mainly focuses on physical activity and nutrition supplementation such as vitamin D [1]. A large number of clinical studies have investigated the effects of physical activity and vitamin D supplementation on muscle mass and strength singly or combinedly [13, 15Not reported18]. However, there is still inconsistent in results. A network meta-analysis of randomized controlled trials found that combining vitamin D supplementation with protein supplementation and exercise can significantly increase grip strength, which indicates that adding vitamin D to a standard treatment protocol for sarcopenia may be helpful for regaining function [18].

Vitamin D status seems to be an important factor for intervention to sarcopenia in clinical studies.

Therefore, the major purpose of this study was to examine whether the role of physical activity and vitamin D in sarcopenia, obesity, and sarcopenic obesity was different between men and women. The secondary objective was to investigate the relationship of physical activity and sarcopenia by different vitamin D status to examine whether vitamin D status is a modifier in this relationship.

Source: Background Source: Background Source: Background Source: Background

Study methods

What methods does the paper describe?

Study design and participants

Data used in the present study are from the baseline survey of West China Health and Aging Trend (WCHAT) study [19]. A total of 7536 community-dwelling participants aged ≥ 50 years were enrolled at baseline survey in July 2018. Face-to-face interviews were performed by trained interviewers. Information on demographics, health and chronic diseases, physical performance, anthropometric measurements, body composition, and fasting blood were collected. This study was approved by the Ethics Committee of West China Hospital, Sichuan University and conducted in accordance with the Declaration of Helsinki.

This study was registered at the China Clinical Trial Center (Registration Number: ChiCTR1800018895). All participants signed the informed consent before participating.

After excluding 3474 participants who have missing data on grip strength, skeletal muscle mass index (SMI) and Short Physical Performance Battery (SPPB), 74 missing data on vitamin D, and 275 missing data on covariates, 3713 participants aged 50 years and older were included in the final analysis.

Definitions of obesity, sarcopenia, and sarcopenic obesity

We define obesity based on two different obesity markers: a) body mass index (BMI) ≥ 28.0 kg/m2 [20]; b) body fat percentage (based on bioelectrical impedance analysis) ≥ 60th percentile of the weighted sample distribution, adjusting for sex (in our population, the cut-off values was 30.35% in male and 38.64% in female, respectively). Participants were defined as obese if they met either of these two criteria.

Sarcopenia was defined according to the Asian Working Group for Sarcopenia (AWGS) 2019 consensus [21], which included low muscle strength (handgrip strength: < 28 kg for male, < 18 kg for female), low muscle mass (Appendicular skeletal muscle mass index (ASMI, ASM/height2): bioelectrical impedance analysis (BIA): < 7.0 kg/m2 for male, 5.7 kg/m2 for female), and poor physical performance assessed by Short Physical Performance Battery (SPPB ≤ 9). Combination of low muscle mass and low muscle strength (or low physical performance) was defined as sarcopenia.

Muscle mass was measured with a bioelectrical impedance analyzer (Inbody 770, BioSpace, Seoul, Korea), which is a simple, and precise method for assessment of skeletal muscle mass. Handgrip strength was measured with the dominant hand using a dynamometer (EH101; Camry, Zhongshan, China). Two tests were performed and the highest value was considered. We used SPPB to assess physical performance, which included standing balance test, 4-m walk time and 5-time chair stand test. The total score ranges from 0 to 12, and participants scoring 9 and less are considered low physical performance.

Participants were categorized into four groups: 1) Normal (N): neither obesity nor sarcopenia; 2) Obesity (O): only presence of obesity; 3) Sarcopenia (S): only presence of sarcopenia; 4) Sarcopenic obesity (SO): both presence of obesity and sarcopenia.

Physical activity assessment

Self-reported physical activity (PA) was evaluated by a validated China Leisure Time Physical Activity Questionnaire (CLTPAQ) [22], which was a modified version of the Minnesota Leisure Time Physical Activity Questionnaire (MLTPAQ) [23] according to the Chinese lifestyles and cultural background. The CLTPAQ consists the frequency and duration of common activities in the last two weeks: walking, indoor housework (such as scrubbing the windows, or mopping the floor), outdoor housework (such as cleaning the yard (terrace), tidying up the garden, or shoveling snow), dancing and other regular activities (such as strength exercises, swimming, cycling, jogging, or tai chi).

We calculated the energy consumption per week according to metabolic equivalents of task (MET) of each type of activity [24]. (Note: energy consumption (kcal /week) = MET * Times per week * Minutes per time * Weight(kg)/60). walking (4.0 MET), indoor housework (3.5 MET), outdoor housework (5.0 MET), dancing (4.5 MET), and other regular exercises such as swimming, jogging (5.0 MET)). Physical activity level was divided into two groups according to the 20th percentile of energy consumption per week, adjusting for sex.

Moderate to high physical activity was defined as being ≥ the 20th percentile of energy consumption per week. Low physical activity was defined as being < the 20th percentile of energy consumption per week.

Serum vitamin D measurement

Venous blood samples were collected after an overnight fast to measure biochemical parameters. Serum 25(OH)D concentration (ng/mL) was performed using chemiluminescent microparticle immunoassay (Abbott i2005R, USA). Participants were classified into two groups according to serum vitamin D concentration: vitamin D deficiency (25(OH)D < 20 ng/ml) and vitamin D insufficiency or sufficiency (25(OH)D ≥ 20 ng/ml). All laboratory evaluations were performed by trained clinical laboratory technicians in accordance with standard operating procedures in hospital laboratories.

Covariates

Demographics and lifestyle data including age, sex, ethnicity, education (illiterate, primary school, middle school, high school and above), marital status (married, single/divorced/widowed), smoking history were collected. Self-reported diagnosed chronic diseases, including hypertension, diabetes mellitus, coronary heart diseases, chronic obstructive pulmonary diseases (COPD), arthritis, stroke, and tumor were also interviewed. We also included disability in activities of daily living (ADL disability). ADL disability was defined as having needs for assistance or difficulty in one or more of the ten items in Barthel Index [25].

Nutrition status was evaluated with the Mini Nutrition Assessment-Short form (MNA-SF) [26] with 8 to 11 points indicating risk of malnutrition and < 8 points indicating malnutrition.

Statistical analysis

Statistical analysis was performed using Stata15.1 (Stata Corp, College Station, TX, USA). We investigated participants’ characteristics using descriptive statistics and appropriate statistical tests. For descriptive analysis, continuous variables are expressed as the mean ± standard deviation (SD), and categorical variables are expressed as number (%). Group differences were evaluated using the Student’s t-test for continuous variables and the chi-squared tests for categorical variables.

We used multinomial logistic regression to examine the relationship between PA levels (exposure, binary variable), vitamin D status (exposure, binary variable), and obesity or sarcopenia status (outcome, categorial variable). We also conducted sex subgroup analysis to explore the different role of PA and vitamin D in obesity and sarcopenia in men and women. Furthermore, we investigated the relationship of PA and obesity/sarcopenia at different vitamin D status to explore whether vitamin D could modify this relationship. All regression models were adjusted for age, sex, ethnicity, education, marital status, smoking history, common chronic diseases, ADL disability, and nutrition status.

Two-sided p < 0.05 was considered statistically significant.

Source: Methods Source: Methods Source: Methods Source: Methods Source: Methods Source: Methods

Results: Characteristics of participants

A total of 3713 participants aged 50 years and older were included our analysis. The mean age was 61.9 years (SD 8.0), and 42% were aged < 60 years (Table 1). For the whole sample, 1351 (36.4%) were men. The prevalence of obesity, sarcopenia and sarcopenic obesity were 37.8%, 12.6%, and 4.8%, respectively. The mean concentration of 25(OH)D was 19.2 ng/ml (SD 6.3), and 17.8% participants were identified as low PA. 59.3% participants had vitamin D deficiency (25(OH)D < 20 ng/ml).

There were significant differences between male and female on demographic and some chronic diseases. Compared with men, women were younger (Table 1). The vitamin D concentration of men was significantly higher than women, while the prevalence of low PA in men was higher than that in women. Compared with women, men were more likely to be sarcopenia and sarcopenic obesity.

Table 1

Characteristics of participants according to sex (N = 3713)

CharacteristicsTotal
(n = 3713)
Male
(n = 1351)
Female
(n = 2362)
P value
Age(years), mean (SD)61.9(8.0)63.5(8.1)61.0(7.8) < 0.001
< 60y, n (%)1528(41.2)441(32.6)1087(46.0) < 0.001
 ≥ 60y, n (%)2185(58.8)910(67.4)1275(54)
Ethnicity, n (%) < 0.001
 Han1628(43.8)538(39.8)1090(46.1)
 Qiang936(25.2)329(24.4)607(25.7)
 Tibetan931(25.1)403(29.8)528(22.4)
 Others218(5.9)81(6.0)137(5.8)
Education, n (%) < 0.001
 Illiterate1068(28.8)219(16.2)849(35.9)
 Elementary1274(34.3)532(39.4)742(31.4)
 Middle832(22.4)326(24.1)506(21.4)
 High and above539(14.5)274(20.3)265(11.2)
Marital status, n (%) < 0.001
 Married3184(84.7)1229(91.0)1921(81.3)
 Single/divorced/widowed575(15.3)122(9.0)441(18.7)
Smoking history, n (%) < 0.001
 Yes657(17.7)609(45.1)48(2.0)
 No3056(82.3)742(54.9)2314(98.0)
Chronic diseases, n (%)
 Hypertention930(25.1)349(25.8)581(24.6)0.40
 COPD113(3.0)16(1.2)18(0.8)0.19
 Coronary heart disease34(0.9)47(3.5)66(2.8)0.24
 Diabetes264(7.1)113(8.4)151(6.4)0.025
 Arthritis330(8.9)102(7.5)228(9.7)0.030
 Stroke63(1.7)27(2.0)36(1.5)0.28
 Tumor26(0.7)4(0.3)22(0.9)0.026
Nutrition status, n (%)0.074
 Normal3015(81.2)1106(81.9)1909(80.8)
 Risk of malnutrition680(18.3)243(18.0)437(18.5)
 Malnutrition18(0.5)2(0.1)16(0.7)
ADL disability, n (%)351(9.5)128(9.5)223(9.4)0.97
Vitamin D (ng/ml), mean (SD)19.2(6.3)21.4(6.5)18.0(5.8) < 0.001
Vitamin D status, n (%) < 0.001
  < 20 ng/ml2203(59.3)609(45.1)1594(67.5)
  ≥ 20 ng/ml1510(40.7)742(54.9)768(32.5)
PA levels, n (%) < 0.001
 Moderate to high3053(82.2)1041(77.1)2012(85.2)
 Low660(17.8)310(22.9)350(14.8)
Sarcopenia and Obesity, n (%) < 0.001
 N1665(44.8)583(43.2)1082(45.8)
 O1404(37.8)485(35.9)919(38.9)
 S467(12.6)190(14.1)277(11.7)
 SO177(4.8)93(6.9)84(3.6)

Abbreviations: ADL Activity of daily living, PA Physical activity, N Normal, O Obesity, S Sarcopenia, SO Sarcopenic obesity

Source: Characteristics of participants

Relationship of physical activity, vitamin D, with obesity, sarcopenia and sarcopenic obesity

Results: Relationship of physical activity, vitamin D, with obesity, sarcopenia and sarcopenic obesity

Table 2 shows the results of multinomial logistic regressions of associations between PA, vitamin D and sarcopenia. In total sample, after adjusting for confounding variables, low PA was significantly associated with higher odds of sarcopenia (OR = 1.65, 95%CI: 1.25,2.18, p < 0.001). Vitamin D deficiency was significantly associated with obesity, sarcopenia, and sarcopenic obesity (OR = 1.57, 95%CI: 1.34,1.84, p < 0.001, OR = 1.31, 95%CI: 1.03,1.66, p = 0.029, and OR = 1.88, 95%CI: 1.32,2.67, p < 0.001, respectively).

In subgroup analysis, low PA was significantly associated with sarcopenia only in women. Vitamin D deficiency was independently associated with obesity, sarcopenia, and sarcopenic obesity in men, while significant association was only observed for obesity and sarcopenic obesity in women.

Table 2

Associations between physical activity, vitamin D and obesity/sarcopenia in total sample and sex subgroup

GroupsORs(95%CI)
O vs NS vs NSO vs N
Total sample (n = 3713)
 PA levels
  Moderate to high1(reference)1(reference)1(reference)
  Low1.19(0.97,1.47)1.65(1.25,2.18) ***1.48(1.00,2.19)
 Vitamin D
   ≥ 20 ng/ml1(reference)1(reference)1(reference)
   < 20 ng/ml1.57(1.34,1.84) ***1.31(1.03,1.66) *1.88(1.32,2.67) ***
Male (n = 1351)
 PA levels
  Moderate to high1(reference)1(reference)1(reference)
  Low1.38(1.00,1.91)1.56(1.00,2.42)1.54(0.89,2.68)
 Vitamin D
   ≥ 20 ng/ml1(reference)1(reference)1(reference)
   < 20 ng/ml1.75(1.34,2.28) ***1.85(1.27,2.69) **2.05(1.28,3.30) **
Female (n = 2362)
 PA levels
  Moderate to high1(reference)1(reference)1(reference)
  Low1.05(0.79,1.38)1.70(1.18,2.46) **1.58(0.90,2.80)
 Vitamin D
   ≥ 20 ng/ml1(reference)1(reference)1(reference)
   < 20 ng/ml1.47(1.20,1.79) ***1.06(0.77,1.45)1.93(1.11,3.37) *

In total sample adjusted age, sex, ethnicity, education, marital status, smoking, ADL disability, chronic diseases (hypertention, coronary heart diseases, COPD, diabetes, stroke, arthritis, tumor), nutrition status, physical activity, and vitamin D status. In sex subgroups, adjusted all variables in total sample analysis except for sex

Abbreviations: ORs Odds ratios, CI Confident interval, N Normal, O Obesity, S Sarcopenia, SO Sarcopenic obesity, PA Physical activity

*p < 0.05, **p < 0.01, ***p < 0.001

Source: Relationship of physical activity, vitamin D, with obesity, sarcopenia and sarcopenic obesity

Subgroup analysis of vitamin D status in the relationship of physical activity with obesity, sarcopenia, and sarcopenic obesity

Results: Subgroup analysis of vitamin D status in the relationship of physical activity with obesity, sarcopenia, and sarcopenic obesity

Table 3 presents the relationships of physical activity levels and sarcopenia according to vitamin D status. Low PA was only significantly associated with obesity, sarcopenia and sarcopenic obesity in participants who had vitamin D deficiency (OR = 1.38, p < 0.05, OR = 1.96, p < 0.001 and OR = 1.85, p < 0.05, respectively).

Table 3

Association between physical activity and obesity/sarcopenia by vitamin D status

Vitamin D subgroupsORs(95%CI)
O vs NS vs NSO v N
Vitamin D < 20 ng/ml (n = 2203) a
  Moderate to high1(reference)1(reference)1(reference)
  Low1.38(1.04,1.83) *1.96(1.34,2.85) ***1.85(1.14,3.01) *
Vitamin D ≥ 20 ng/ml (n = 1510) a
  Moderate to high1(reference)1(reference)1(reference)
  Low0.98(0.71,1.35)1.41(0.91,2.15)1.07(0.53,2.13)

Abbreviations: ORs Odds ratios, CI Confident interval, N Normal, O Obesity, S Sarcopenia, SO Sarcopenic obesity

a Adjusted age, sex, ethnicity, education, marital status, smoking, ADL disability, chronic diseases (hypertention, coronary heart diseases, COPD, diabetes, stroke, arthritis, tumor), nutrition status

*p < 0.05, **p < 0.01, ***p < 0.001

Source: Subgroup analysis of vitamin D status in the relationship of physical activity with obesity, sarcopenia, and sarcopenic obesity

Discussion

The present study adds evidence to the sex-specific relationships between vitamin D status, PA levels, sarcopenia, obesity and sarcopenic obesity among middle aged and older people in west China. Vitamin D deficiency, defined as total 25(OH)D < 20 ng/ml, was found to be associated with sarcopenia only in men, and low PA was found to be associated with greater odds of sarcopenia only in women. Vitamin D deficiency was independently associated with obesity and sarcopenic obesity both in men and women.

We also found vitamin D status modified the association between PA and sarcopenia. Specifically, among participants with 25(OH)D < 20 ng/ml, low PA was associated with increased risk of sarcopenia, whereas there was no significant association among those with 25(OH)D ≥ 20 ng/ml.

Consistent with previous studies, our study confirmed that physical inactivity and vitamin D deficiency were associated with sarcopenia [27, 28]. Additionally, we found that the role of vitamin D and PA in sarcopenia was not equally important in men and women. Previous studies investigating the relation between vitamin D and sarcopenia have yielded conflicting results. In line with a previous study conducted by Spira et al. [12], vitamin D deficiency was significantly associated with sarcopenia only in men.

In contrast, Park et al. [11] found a positive association of vitamin D deficiency and sarcopenia in ≥ 50 years old women, but not men [11]. These inconsistent results may be explained by different population and definitions of sarcopenia. Differences between men and women in many characteristics may be potential confounders affecting this relationship. For example, different rates of decline of hormones such as testosterone and estrogen in different life stages in men and women [29].

The hormonal changes of female menopause may outweigh the effect of a low vitamin D level on muscle mass. For men, the decline of testosterone usually occurs at an older age, therefore, a low vitamin D level might be more crucial concerning the onset of sarcopenia [12, 29]. Furthermore, vitamin D is inversely associated with obesity and their relationship may be bi-directional [30]. Women had higher total fat mass than men, which may lead to sequestration of the fat-soluble vitamin D in fat tissue and therefore decreased bioavailability of vitamin D3 [31].

This may be one reason why women had a lower 25(OH)D concentration than men. Therefore, fat mass likely might be a moderator and mediator of the relationship between vitamin D deficiency and sarcopenia.

Compared with the role of vitamin D in sarcopenia development in men, physical inactivity was the main contributor to developing sarcopenia in women. Previous studies have found that low PA was significantly associated with sarcopenia [32, 33]. In our results, low PA was found to be associated with sarcopenia only in women. A meta-analysis indicated that PA can significantly reduce the odds of both males and females suffering from sarcopenia (OR = 0.46, 95%CI: 0.37,0.58, and OR = 0.65, 95%CI: 0.52,0.81, respectively) [33].

We did not find a positive results in men, which may be explained by a relatively small sample in men and different methods of assessing PA. Although the definition of low physical activity was adjusted for sex in the present study. Physical activity in men is usually higher than that of women. Additionally, other factors may interact with physical activity, thus weakening the role of physical activity in sarcopenia.

Other possible factors cannot be completely ruled out, and more studies are still needed to further prove.

Low serum vitamin D was found to be associated with obesity and sarcopenic obesity regardless of sex. The inverse association between vitamin D and obesity has been established in the literature [10]. A large meta-analysis has shown that BMI-related genetic variants were associated with both BMI and vitamin D levels, while vitamin D-related genetic variants were only associated with vitamin D status but not BMI, which support the hypothesis that obesity may lead to low vitamin D level [30].

This result indicated that weight or percentage of fat mass loss may increase serum 25(OH)D [30].

Serum vitamin D status was an important modifier in the relationship between PA and sarcopenia. As shown in our results, participants with low PA had higher odds of sarcopenia and sarcopenic obesity when participants had vitamin D deficiency. However, low PA was not significantly associated with sarcopenia and sarcopenic obesity among participants with higher concentration of vitamin D (25(OH)D ≥ 20 ng/ml). Another cross-sectional study conducted by Yang et al. found that vitamin D and PA had an interactive effect on sarcopenia.

The effects of vitamin D on sarcopenia may be affected by the level of PA, and the effects of PA may also be affected by vitamin D levels [14]. Yang et al. also found that activity limitation reduced the muscle fiber cross-sectional area and muscle weight in mice, and vitamin D deficiency accelerated the decrease in muscle weight, muscle fiber CSA, and grip strength. In addition, vitamin D supplementation may inhibit the grip strength reduction induced by limited activity [14].

These results may explain the controversial effects of vitamin D or exercise training on muscle mass and muscle function in clinical trials. The results of vitamin D supplementation or exercise therapy may be affected by differences in baseline PA levels and serum 25(OH)D levels in older adults. These findings indicated that participants with inactivity were important population to screen serum vitamin D status. And for them, maintaining sufficient vitamin D may reduce the risk of developing sarcopenia and sarcopenic obesity.

Our study had some strengths. First, WCHAT is a relatively large population-based study, and complete information on physical and health conditions was collected through standardized and structured interviews. Second, diagnosis of sarcopenia was based on the AWGS 2019 consensus, and definition of obesity was based on the combination of BMI and fat mass percentage assessed by BIA, which were more accurate and standard. However, several limitations should be considered in our current study when interpreting the results. First, cross-sectional analyses cannot elucidate any determination of the temporal nature of the associations between variables, for which longitudinal studies are required.

Second, PA evaluation was based on self-reporting not accelerometer-measured physical activities, so potential recall bias may exist. Finally, our study population were from multiple ethnic groups. Although we adjusted for ethnicity in the regression models, the differences in vitamin D levels and PA habits between ethnic groups and whether these differences influence the relationships of them are not clear.

This study has several implications for prevention and intervention to sarcopenia in older people. Firstly, it is recommended that simultaneous screening for vitamin D levels and evaluating levels of PA in older adults. Older adults should strive to avoid both physical inactivity and vitamin D deficiency. Secondly, supplementing vitamin D may help reduce the risk of sarcopenia in individuals with physical inactivity or physical limitations. Thirdly, women are encouraged to increase PA, while men should maintain adequate vitamin D levels.

In the future clinical trials for sarcopenia, the intervention strategies for men and women should be different or individualized.

Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion

Results

Characteristics of participants

A total of 3713 participants aged 50 years and older were included our analysis. The mean age was 61.9 years (SD 8.0), and 42% were aged < 60 years (Table 1). For the whole sample, 1351 (36.4%) were men. The prevalence of obesity, sarcopenia and sarcopenic obesity were 37.8%, 12.6%, and 4.8%, respectively. The mean concentration of 25(OH)D was 19.2 ng/ml (SD 6.3), and 17.8% participants were identified as low PA. 59.3% participants had vitamin D deficiency (25(OH)D < 20 ng/ml).

There were significant differences between male and female on demographic and some chronic diseases. Compared with men, women were younger (Table 1). The vitamin D concentration of men was significantly higher than women, while the prevalence of low PA in men was higher than that in women. Compared with women, men were more likely to be sarcopenia and sarcopenic obesity.

Table 1

Characteristics of participants according to sex (N = 3713)

CharacteristicsTotal
(n = 3713)
Male
(n = 1351)
Female
(n = 2362)
P value
Age(years), mean (SD)61.9(8.0)63.5(8.1)61.0(7.8) < 0.001
< 60y, n (%)1528(41.2)441(32.6)1087(46.0) < 0.001
 ≥ 60y, n (%)2185(58.8)910(67.4)1275(54)
Ethnicity, n (%) < 0.001
 Han1628(43.8)538(39.8)1090(46.1)
 Qiang936(25.2)329(24.4)607(25.7)
 Tibetan931(25.1)403(29.8)528(22.4)
 Others218(5.9)81(6.0)137(5.8)
Education, n (%) < 0.001
 Illiterate1068(28.8)219(16.2)849(35.9)
 Elementary1274(34.3)532(39.4)742(31.4)
 Middle832(22.4)326(24.1)506(21.4)
 High and above539(14.5)274(20.3)265(11.2)
Marital status, n (%) < 0.001
 Married3184(84.7)1229(91.0)1921(81.3)
 Single/divorced/widowed575(15.3)122(9.0)441(18.7)
Smoking history, n (%) < 0.001
 Yes657(17.7)609(45.1)48(2.0)
 No3056(82.3)742(54.9)2314(98.0)
Chronic diseases, n (%)
 Hypertention930(25.1)349(25.8)581(24.6)0.40
 COPD113(3.0)16(1.2)18(0.8)0.19
 Coronary heart disease34(0.9)47(3.5)66(2.8)0.24
 Diabetes264(7.1)113(8.4)151(6.4)0.025
 Arthritis330(8.9)102(7.5)228(9.7)0.030
 Stroke63(1.7)27(2.0)36(1.5)0.28
 Tumor26(0.7)4(0.3)22(0.9)0.026
Nutrition status, n (%)0.074
 Normal3015(81.2)1106(81.9)1909(80.8)
 Risk of malnutrition680(18.3)243(18.0)437(18.5)
 Malnutrition18(0.5)2(0.1)16(0.7)
ADL disability, n (%)351(9.5)128(9.5)223(9.4)0.97
Vitamin D (ng/ml), mean (SD)19.2(6.3)21.4(6.5)18.0(5.8) < 0.001
Vitamin D status, n (%) < 0.001
  < 20 ng/ml2203(59.3)609(45.1)1594(67.5)
  ≥ 20 ng/ml1510(40.7)742(54.9)768(32.5)
PA levels, n (%) < 0.001
 Moderate to high3053(82.2)1041(77.1)2012(85.2)
 Low660(17.8)310(22.9)350(14.8)
Sarcopenia and Obesity, n (%) < 0.001
 N1665(44.8)583(43.2)1082(45.8)
 O1404(37.8)485(35.9)919(38.9)
 S467(12.6)190(14.1)277(11.7)
 SO177(4.8)93(6.9)84(3.6)

Abbreviations: ADL Activity of daily living, PA Physical activity, N Normal, O Obesity, S Sarcopenia, SO Sarcopenic obesity

Relationship of physical activity, vitamin D, with obesity, sarcopenia and sarcopenic obesity

Table 2 shows the results of multinomial logistic regressions of associations between PA, vitamin D and sarcopenia. In total sample, after adjusting for confounding variables, low PA was significantly associated with higher odds of sarcopenia (OR = 1.65, 95%CI: 1.25,2.18, p < 0.001). Vitamin D deficiency was significantly associated with obesity, sarcopenia, and sarcopenic obesity (OR = 1.57, 95%CI: 1.34,1.84, p < 0.001, OR = 1.31, 95%CI: 1.03,1.66, p = 0.029, and OR = 1.88, 95%CI: 1.32,2.67, p < 0.001, respectively).

In subgroup analysis, low PA was significantly associated with sarcopenia only in women. Vitamin D deficiency was independently associated with obesity, sarcopenia, and sarcopenic obesity in men, while significant association was only observed for obesity and sarcopenic obesity in women.

Table 2

Associations between physical activity, vitamin D and obesity/sarcopenia in total sample and sex subgroup

GroupsORs(95%CI)
O vs NS vs NSO vs N
Total sample (n = 3713)
 PA levels
  Moderate to high1(reference)1(reference)1(reference)
  Low1.19(0.97,1.47)1.65(1.25,2.18) ***1.48(1.00,2.19)
 Vitamin D
   ≥ 20 ng/ml1(reference)1(reference)1(reference)
   < 20 ng/ml1.57(1.34,1.84) ***1.31(1.03,1.66) *1.88(1.32,2.67) ***
Male (n = 1351)
 PA levels
  Moderate to high1(reference)1(reference)1(reference)
  Low1.38(1.00,1.91)1.56(1.00,2.42)1.54(0.89,2.68)
 Vitamin D
   ≥ 20 ng/ml1(reference)1(reference)1(reference)
   < 20 ng/ml1.75(1.34,2.28) ***1.85(1.27,2.69) **2.05(1.28,3.30) **
Female (n = 2362)
 PA levels
  Moderate to high1(reference)1(reference)1(reference)
  Low1.05(0.79,1.38)1.70(1.18,2.46) **1.58(0.90,2.80)
 Vitamin D
   ≥ 20 ng/ml1(reference)1(reference)1(reference)
   < 20 ng/ml1.47(1.20,1.79) ***1.06(0.77,1.45)1.93(1.11,3.37) *

In total sample adjusted age, sex, ethnicity, education, marital status, smoking, ADL disability, chronic diseases (hypertention, coronary heart diseases, COPD, diabetes, stroke, arthritis, tumor), nutrition status, physical activity, and vitamin D status. In sex subgroups, adjusted all variables in total sample analysis except for sex

Abbreviations: ORs Odds ratios, CI Confident interval, N Normal, O Obesity, S Sarcopenia, SO Sarcopenic obesity, PA Physical activity

*p < 0.05, **p < 0.01, ***p < 0.001

Subgroup analysis of vitamin D status in the relationship of physical activity with obesity, sarcopenia, and sarcopenic obesity

Table 3 presents the relationships of physical activity levels and sarcopenia according to vitamin D status. Low PA was only significantly associated with obesity, sarcopenia and sarcopenic obesity in participants who had vitamin D deficiency (OR = 1.38, p < 0.05, OR = 1.96, p < 0.001 and OR = 1.85, p < 0.05, respectively).

Table 3

Association between physical activity and obesity/sarcopenia by vitamin D status

Vitamin D subgroupsORs(95%CI)
O vs NS vs NSO v N
Vitamin D < 20 ng/ml (n = 2203) a
  Moderate to high1(reference)1(reference)1(reference)
  Low1.38(1.04,1.83) *1.96(1.34,2.85) ***1.85(1.14,3.01) *
Vitamin D ≥ 20 ng/ml (n = 1510) a
  Moderate to high1(reference)1(reference)1(reference)
  Low0.98(0.71,1.35)1.41(0.91,2.15)1.07(0.53,2.13)

Abbreviations: ORs Odds ratios, CI Confident interval, N Normal, O Obesity, S Sarcopenia, SO Sarcopenic obesity

a Adjusted age, sex, ethnicity, education, marital status, smoking, ADL disability, chronic diseases (hypertention, coronary heart diseases, COPD, diabetes, stroke, arthritis, tumor), nutrition status

*p < 0.05, **p < 0.01, ***p < 0.001

Source: Results Source: Results Source: Results

Conclusion

The role of vitamin D and PA in sarcopenia was different between men and women, and the relationship between PA and sarcopenia modified by serum vitamin D status. These findings highlighted the need to supplement vitamin D in individuals with physical inactivity and provide different interventions strategies to sarcopenia in men and women.

Source: Conclusion
Authors’ abstract

Background

The relationship between vitamin D and sarcopenia was inconsistent between men and women. Physical activity (PA) may interact with vitamin D on sarcopenia. However, the sex-specific relationships of vitamin D, PA and sarcopenia have yet elucidated. We aimed to examine the sex differences in the relation between vitamin D status, PA levels, obesity and sarcopenia in community-dwelling middle-aged and older adults, as well as whether vitamin D status is a modifier in the relationship between PA and sarcopenia.

Methods

The current study was a cross-sectional study based on the baseline survey of the West China Health and Aging Trend (WCHAT) study. A total of 3713 participants aged ≥ 50y were included in our study. Sarcopenia was defined according to the Asian Working Group for Sarcopenia (AWGS) 2019 consensus. Obesity was defined by body mass index (BMI) (≥ 28 kg/m2) and body fat mass percentage (≥ 60th percentile in each sex group). 25-hydroxyvitamin D was measured by chemiluminescent microparticle immunoassay and PA was evaluated by a validated China Leisure Time Physical Activity Questionnaire (CLTPAQ).

Multinomial logistic regression was performed to examine the relationship between PA, vitamin D and sarcopenia and obesity.

Results

Low PA was significantly associated with higher odds of sarcopenia in women only (OR = 1.70,95%CI:1.18,2.46, p < 0.01). Vitamin D deficiency was only associated with sarcopenia in men (OR = 1.85,95%CI: 1.27,2.69, p < 0.01). Low PA was significantly associated with obesity, sarcopenia, and sarcopenic obesity only in participants with serum 25(OH)D < 20 ng/ml.

Conclusions

The role of vitamin D and PA in obesity and sarcopenia was different between men and women, and the relationship between PA and sarcopenia was modified by serum vitamin D status. These findings highlighted the need to supplement vitamin D in individuals with physical inactivity and provide different interventions strategies to sarcopenia in men and women.

Trial registration

Clinical trial number: ChiCTR1800018895.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12877-022-03577-4.

Read the full paper

Background

Sarcopenia is an age-related skeletal muscle disorder defined as accelerated loss of muscle mass and function [1]. Sarcopenia is associated with multiple adverse outcomes such as falls, physical disability, frailty and premature death [1]. In parallel with the development of sarcopenia, the prevalence of obesity is also rising with aging [2]. The concurrent presence of both sarcopenia and obesity in the same individual is defined as sarcopenic obesity (SO), which is a better predictor of negative health outcomes in older than sarcopenia or obesity alone [2, 3].

Physical inactivity and vitamin D deficiency often co-exist in older adults, and they are both risk factors for sarcopenia and obesity [1, 4, 5]. Previous studies have reported the role of vitamin D in the development of sarcopenia [6]. Serum levels of vitamin D are independently related to the loss of muscle mass and strength [7], particular in men [8]. Vitamin D deficiency is frequently observed in obese [9].

Evidence from observational studies suggests that obesity is associated with low vitamin D status as a result of the inverse between serum 25(OH)D concentration and body fat mass [10]. To our knowledge, studies related to the associations of physical activity levels, vitamin D, and sarcopenic obesity are limited. There are differences in physical activity levels and vitamin D between males and females. Vitamin D deficiency or physical inactivity as risk factor for sarcopenia may not be equally important in men and women.

Sex differences were often reported in the relationship between vitamin D and sarcopenia [11, 12], or in the effect of vitamin D supplementation on sarcopenia [13].

Physical inactivity and vitamin D deficiency may have synergistic effects on muscle degradation and exacerbate sarcopenia [14]. A previous study explored the interactive effect of vitamin D and physical activity on muscle mass and function through animal experiments and population surveys [14]. They concluded that the effect of vitamin D on sarcopenia depends on the level of physical activity in older adults [14]. Specifically, physical activity levels modified the relationship of vitamin D and sarcopenia.

At present, the treatment of sarcopenia mainly focuses on physical activity and nutrition supplementation such as vitamin D [1]. A large number of clinical studies have investigated the effects of physical activity and vitamin D supplementation on muscle mass and strength singly or combinedly [13, 15Not reported18]. However, there is still inconsistent in results. A network meta-analysis of randomized controlled trials found that combining vitamin D supplementation with protein supplementation and exercise can significantly increase grip strength, which indicates that adding vitamin D to a standard treatment protocol for sarcopenia may be helpful for regaining function [18].

Vitamin D status seems to be an important factor for intervention to sarcopenia in clinical studies.

Therefore, the major purpose of this study was to examine whether the role of physical activity and vitamin D in sarcopenia, obesity, and sarcopenic obesity was different between men and women. The secondary objective was to investigate the relationship of physical activity and sarcopenia by different vitamin D status to examine whether vitamin D status is a modifier in this relationship.

Methods

Study design and participants

Data used in the present study are from the baseline survey of West China Health and Aging Trend (WCHAT) study [19]. A total of 7536 community-dwelling participants aged ≥ 50 years were enrolled at baseline survey in July 2018. Face-to-face interviews were performed by trained interviewers. Information on demographics, health and chronic diseases, physical performance, anthropometric measurements, body composition, and fasting blood were collected. This study was approved by the Ethics Committee of West China Hospital, Sichuan University and conducted in accordance with the Declaration of Helsinki.

This study was registered at the China Clinical Trial Center (Registration Number: ChiCTR1800018895). All participants signed the informed consent before participating.

After excluding 3474 participants who have missing data on grip strength, skeletal muscle mass index (SMI) and Short Physical Performance Battery (SPPB), 74 missing data on vitamin D, and 275 missing data on covariates, 3713 participants aged 50 years and older were included in the final analysis.

Definitions of obesity, sarcopenia, and sarcopenic obesity

We define obesity based on two different obesity markers: a) body mass index (BMI) ≥ 28.0 kg/m2 [20]; b) body fat percentage (based on bioelectrical impedance analysis) ≥ 60th percentile of the weighted sample distribution, adjusting for sex (in our population, the cut-off values was 30.35% in male and 38.64% in female, respectively). Participants were defined as obese if they met either of these two criteria.

Sarcopenia was defined according to the Asian Working Group for Sarcopenia (AWGS) 2019 consensus [21], which included low muscle strength (handgrip strength: < 28 kg for male, < 18 kg for female), low muscle mass (Appendicular skeletal muscle mass index (ASMI, ASM/height2): bioelectrical impedance analysis (BIA): < 7.0 kg/m2 for male, 5.7 kg/m2 for female), and poor physical performance assessed by Short Physical Performance Battery (SPPB ≤ 9). Combination of low muscle mass and low muscle strength (or low physical performance) was defined as sarcopenia.

Muscle mass was measured with a bioelectrical impedance analyzer (Inbody 770, BioSpace, Seoul, Korea), which is a simple, and precise method for assessment of skeletal muscle mass. Handgrip strength was measured with the dominant hand using a dynamometer (EH101; Camry, Zhongshan, China). Two tests were performed and the highest value was considered. We used SPPB to assess physical performance, which included standing balance test, 4-m walk time and 5-time chair stand test. The total score ranges from 0 to 12, and participants scoring 9 and less are considered low physical performance.

Participants were categorized into four groups: 1) Normal (N): neither obesity nor sarcopenia; 2) Obesity (O): only presence of obesity; 3) Sarcopenia (S): only presence of sarcopenia; 4) Sarcopenic obesity (SO): both presence of obesity and sarcopenia.

Physical activity assessment

Self-reported physical activity (PA) was evaluated by a validated China Leisure Time Physical Activity Questionnaire (CLTPAQ) [22], which was a modified version of the Minnesota Leisure Time Physical Activity Questionnaire (MLTPAQ) [23] according to the Chinese lifestyles and cultural background. The CLTPAQ consists the frequency and duration of common activities in the last two weeks: walking, indoor housework (such as scrubbing the windows, or mopping the floor), outdoor housework (such as cleaning the yard (terrace), tidying up the garden, or shoveling snow), dancing and other regular activities (such as strength exercises, swimming, cycling, jogging, or tai chi).

We calculated the energy consumption per week according to metabolic equivalents of task (MET) of each type of activity [24]. (Note: energy consumption (kcal /week) = MET * Times per week * Minutes per time * Weight(kg)/60). walking (4.0 MET), indoor housework (3.5 MET), outdoor housework (5.0 MET), dancing (4.5 MET), and other regular exercises such as swimming, jogging (5.0 MET)). Physical activity level was divided into two groups according to the 20th percentile of energy consumption per week, adjusting for sex.

Moderate to high physical activity was defined as being ≥ the 20th percentile of energy consumption per week. Low physical activity was defined as being < the 20th percentile of energy consumption per week.

Serum vitamin D measurement

Venous blood samples were collected after an overnight fast to measure biochemical parameters. Serum 25(OH)D concentration (ng/mL) was performed using chemiluminescent microparticle immunoassay (Abbott i2005R, USA). Participants were classified into two groups according to serum vitamin D concentration: vitamin D deficiency (25(OH)D < 20 ng/ml) and vitamin D insufficiency or sufficiency (25(OH)D ≥ 20 ng/ml). All laboratory evaluations were performed by trained clinical laboratory technicians in accordance with standard operating procedures in hospital laboratories.

Covariates

Demographics and lifestyle data including age, sex, ethnicity, education (illiterate, primary school, middle school, high school and above), marital status (married, single/divorced/widowed), smoking history were collected. Self-reported diagnosed chronic diseases, including hypertension, diabetes mellitus, coronary heart diseases, chronic obstructive pulmonary diseases (COPD), arthritis, stroke, and tumor were also interviewed. We also included disability in activities of daily living (ADL disability). ADL disability was defined as having needs for assistance or difficulty in one or more of the ten items in Barthel Index [25].

Nutrition status was evaluated with the Mini Nutrition Assessment-Short form (MNA-SF) [26] with 8 to 11 points indicating risk of malnutrition and < 8 points indicating malnutrition.

Statistical analysis

Statistical analysis was performed using Stata15.1 (Stata Corp, College Station, TX, USA). We investigated participants’ characteristics using descriptive statistics and appropriate statistical tests. For descriptive analysis, continuous variables are expressed as the mean ± standard deviation (SD), and categorical variables are expressed as number (%). Group differences were evaluated using the Student’s t-test for continuous variables and the chi-squared tests for categorical variables.

We used multinomial logistic regression to examine the relationship between PA levels (exposure, binary variable), vitamin D status (exposure, binary variable), and obesity or sarcopenia status (outcome, categorial variable). We also conducted sex subgroup analysis to explore the different role of PA and vitamin D in obesity and sarcopenia in men and women. Furthermore, we investigated the relationship of PA and obesity/sarcopenia at different vitamin D status to explore whether vitamin D could modify this relationship. All regression models were adjusted for age, sex, ethnicity, education, marital status, smoking history, common chronic diseases, ADL disability, and nutrition status.

Two-sided p < 0.05 was considered statistically significant.

Results

Characteristics of participants

A total of 3713 participants aged 50 years and older were included our analysis. The mean age was 61.9 years (SD 8.0), and 42% were aged < 60 years (Table 1). For the whole sample, 1351 (36.4%) were men. The prevalence of obesity, sarcopenia and sarcopenic obesity were 37.8%, 12.6%, and 4.8%, respectively. The mean concentration of 25(OH)D was 19.2 ng/ml (SD 6.3), and 17.8% participants were identified as low PA. 59.3% participants had vitamin D deficiency (25(OH)D < 20 ng/ml).

There were significant differences between male and female on demographic and some chronic diseases. Compared with men, women were younger (Table 1). The vitamin D concentration of men was significantly higher than women, while the prevalence of low PA in men was higher than that in women. Compared with women, men were more likely to be sarcopenia and sarcopenic obesity.

Table 1

Characteristics of participants according to sex (N = 3713)

CharacteristicsTotal
(n = 3713)
Male
(n = 1351)
Female
(n = 2362)
P value
Age(years), mean (SD)61.9(8.0)63.5(8.1)61.0(7.8) < 0.001
< 60y, n (%)1528(41.2)441(32.6)1087(46.0) < 0.001
 ≥ 60y, n (%)2185(58.8)910(67.4)1275(54)
Ethnicity, n (%) < 0.001
 Han1628(43.8)538(39.8)1090(46.1)
 Qiang936(25.2)329(24.4)607(25.7)
 Tibetan931(25.1)403(29.8)528(22.4)
 Others218(5.9)81(6.0)137(5.8)
Education, n (%) < 0.001
 Illiterate1068(28.8)219(16.2)849(35.9)
 Elementary1274(34.3)532(39.4)742(31.4)
 Middle832(22.4)326(24.1)506(21.4)
 High and above539(14.5)274(20.3)265(11.2)
Marital status, n (%) < 0.001
 Married3184(84.7)1229(91.0)1921(81.3)
 Single/divorced/widowed575(15.3)122(9.0)441(18.7)
Smoking history, n (%) < 0.001
 Yes657(17.7)609(45.1)48(2.0)
 No3056(82.3)742(54.9)2314(98.0)
Chronic diseases, n (%)
 Hypertention930(25.1)349(25.8)581(24.6)0.40
 COPD113(3.0)16(1.2)18(0.8)0.19
 Coronary heart disease34(0.9)47(3.5)66(2.8)0.24
 Diabetes264(7.1)113(8.4)151(6.4)0.025
 Arthritis330(8.9)102(7.5)228(9.7)0.030
 Stroke63(1.7)27(2.0)36(1.5)0.28
 Tumor26(0.7)4(0.3)22(0.9)0.026
Nutrition status, n (%)0.074
 Normal3015(81.2)1106(81.9)1909(80.8)
 Risk of malnutrition680(18.3)243(18.0)437(18.5)
 Malnutrition18(0.5)2(0.1)16(0.7)
ADL disability, n (%)351(9.5)128(9.5)223(9.4)0.97
Vitamin D (ng/ml), mean (SD)19.2(6.3)21.4(6.5)18.0(5.8) < 0.001
Vitamin D status, n (%) < 0.001
  < 20 ng/ml2203(59.3)609(45.1)1594(67.5)
  ≥ 20 ng/ml1510(40.7)742(54.9)768(32.5)
PA levels, n (%) < 0.001
 Moderate to high3053(82.2)1041(77.1)2012(85.2)
 Low660(17.8)310(22.9)350(14.8)
Sarcopenia and Obesity, n (%) < 0.001
 N1665(44.8)583(43.2)1082(45.8)
 O1404(37.8)485(35.9)919(38.9)
 S467(12.6)190(14.1)277(11.7)
 SO177(4.8)93(6.9)84(3.6)

Abbreviations: ADL Activity of daily living, PA Physical activity, N Normal, O Obesity, S Sarcopenia, SO Sarcopenic obesity

Relationship of physical activity, vitamin D, with obesity, sarcopenia and sarcopenic obesity

Table 2 shows the results of multinomial logistic regressions of associations between PA, vitamin D and sarcopenia. In total sample, after adjusting for confounding variables, low PA was significantly associated with higher odds of sarcopenia (OR = 1.65, 95%CI: 1.25,2.18, p < 0.001). Vitamin D deficiency was significantly associated with obesity, sarcopenia, and sarcopenic obesity (OR = 1.57, 95%CI: 1.34,1.84, p < 0.001, OR = 1.31, 95%CI: 1.03,1.66, p = 0.029, and OR = 1.88, 95%CI: 1.32,2.67, p < 0.001, respectively).

In subgroup analysis, low PA was significantly associated with sarcopenia only in women. Vitamin D deficiency was independently associated with obesity, sarcopenia, and sarcopenic obesity in men, while significant association was only observed for obesity and sarcopenic obesity in women.

Table 2

Associations between physical activity, vitamin D and obesity/sarcopenia in total sample and sex subgroup

GroupsORs(95%CI)
O vs NS vs NSO vs N
Total sample (n = 3713)
 PA levels
  Moderate to high1(reference)1(reference)1(reference)
  Low1.19(0.97,1.47)1.65(1.25,2.18) ***1.48(1.00,2.19)
 Vitamin D
   ≥ 20 ng/ml1(reference)1(reference)1(reference)
   < 20 ng/ml1.57(1.34,1.84) ***1.31(1.03,1.66) *1.88(1.32,2.67) ***
Male (n = 1351)
 PA levels
  Moderate to high1(reference)1(reference)1(reference)
  Low1.38(1.00,1.91)1.56(1.00,2.42)1.54(0.89,2.68)
 Vitamin D
   ≥ 20 ng/ml1(reference)1(reference)1(reference)
   < 20 ng/ml1.75(1.34,2.28) ***1.85(1.27,2.69) **2.05(1.28,3.30) **
Female (n = 2362)
 PA levels
  Moderate to high1(reference)1(reference)1(reference)
  Low1.05(0.79,1.38)1.70(1.18,2.46) **1.58(0.90,2.80)
 Vitamin D
   ≥ 20 ng/ml1(reference)1(reference)1(reference)
   < 20 ng/ml1.47(1.20,1.79) ***1.06(0.77,1.45)1.93(1.11,3.37) *

In total sample adjusted age, sex, ethnicity, education, marital status, smoking, ADL disability, chronic diseases (hypertention, coronary heart diseases, COPD, diabetes, stroke, arthritis, tumor), nutrition status, physical activity, and vitamin D status. In sex subgroups, adjusted all variables in total sample analysis except for sex

Abbreviations: ORs Odds ratios, CI Confident interval, N Normal, O Obesity, S Sarcopenia, SO Sarcopenic obesity, PA Physical activity

*p < 0.05, **p < 0.01, ***p < 0.001

Subgroup analysis of vitamin D status in the relationship of physical activity with obesity, sarcopenia, and sarcopenic obesity

Table 3 presents the relationships of physical activity levels and sarcopenia according to vitamin D status. Low PA was only significantly associated with obesity, sarcopenia and sarcopenic obesity in participants who had vitamin D deficiency (OR = 1.38, p < 0.05, OR = 1.96, p < 0.001 and OR = 1.85, p < 0.05, respectively).

Table 3

Association between physical activity and obesity/sarcopenia by vitamin D status

Vitamin D subgroupsORs(95%CI)
O vs NS vs NSO v N
Vitamin D < 20 ng/ml (n = 2203) a
  Moderate to high1(reference)1(reference)1(reference)
  Low1.38(1.04,1.83) *1.96(1.34,2.85) ***1.85(1.14,3.01) *
Vitamin D ≥ 20 ng/ml (n = 1510) a
  Moderate to high1(reference)1(reference)1(reference)
  Low0.98(0.71,1.35)1.41(0.91,2.15)1.07(0.53,2.13)

Abbreviations: ORs Odds ratios, CI Confident interval, N Normal, O Obesity, S Sarcopenia, SO Sarcopenic obesity

a Adjusted age, sex, ethnicity, education, marital status, smoking, ADL disability, chronic diseases (hypertention, coronary heart diseases, COPD, diabetes, stroke, arthritis, tumor), nutrition status

*p < 0.05, **p < 0.01, ***p < 0.001

Discussion

The present study adds evidence to the sex-specific relationships between vitamin D status, PA levels, sarcopenia, obesity and sarcopenic obesity among middle aged and older people in west China. Vitamin D deficiency, defined as total 25(OH)D < 20 ng/ml, was found to be associated with sarcopenia only in men, and low PA was found to be associated with greater odds of sarcopenia only in women. Vitamin D deficiency was independently associated with obesity and sarcopenic obesity both in men and women.

We also found vitamin D status modified the association between PA and sarcopenia. Specifically, among participants with 25(OH)D < 20 ng/ml, low PA was associated with increased risk of sarcopenia, whereas there was no significant association among those with 25(OH)D ≥ 20 ng/ml.

Consistent with previous studies, our study confirmed that physical inactivity and vitamin D deficiency were associated with sarcopenia [27, 28]. Additionally, we found that the role of vitamin D and PA in sarcopenia was not equally important in men and women. Previous studies investigating the relation between vitamin D and sarcopenia have yielded conflicting results. In line with a previous study conducted by Spira et al. [12], vitamin D deficiency was significantly associated with sarcopenia only in men.

In contrast, Park et al. [11] found a positive association of vitamin D deficiency and sarcopenia in ≥ 50 years old women, but not men [11]. These inconsistent results may be explained by different population and definitions of sarcopenia. Differences between men and women in many characteristics may be potential confounders affecting this relationship. For example, different rates of decline of hormones such as testosterone and estrogen in different life stages in men and women [29].

The hormonal changes of female menopause may outweigh the effect of a low vitamin D level on muscle mass. For men, the decline of testosterone usually occurs at an older age, therefore, a low vitamin D level might be more crucial concerning the onset of sarcopenia [12, 29]. Furthermore, vitamin D is inversely associated with obesity and their relationship may be bi-directional [30]. Women had higher total fat mass than men, which may lead to sequestration of the fat-soluble vitamin D in fat tissue and therefore decreased bioavailability of vitamin D3 [31].

This may be one reason why women had a lower 25(OH)D concentration than men. Therefore, fat mass likely might be a moderator and mediator of the relationship between vitamin D deficiency and sarcopenia.

Compared with the role of vitamin D in sarcopenia development in men, physical inactivity was the main contributor to developing sarcopenia in women. Previous studies have found that low PA was significantly associated with sarcopenia [32, 33]. In our results, low PA was found to be associated with sarcopenia only in women. A meta-analysis indicated that PA can significantly reduce the odds of both males and females suffering from sarcopenia (OR = 0.46, 95%CI: 0.37,0.58, and OR = 0.65, 95%CI: 0.52,0.81, respectively) [33].

We did not find a positive results in men, which may be explained by a relatively small sample in men and different methods of assessing PA. Although the definition of low physical activity was adjusted for sex in the present study. Physical activity in men is usually higher than that of women. Additionally, other factors may interact with physical activity, thus weakening the role of physical activity in sarcopenia.

Other possible factors cannot be completely ruled out, and more studies are still needed to further prove.

Low serum vitamin D was found to be associated with obesity and sarcopenic obesity regardless of sex. The inverse association between vitamin D and obesity has been established in the literature [10]. A large meta-analysis has shown that BMI-related genetic variants were associated with both BMI and vitamin D levels, while vitamin D-related genetic variants were only associated with vitamin D status but not BMI, which support the hypothesis that obesity may lead to low vitamin D level [30].

This result indicated that weight or percentage of fat mass loss may increase serum 25(OH)D [30].

Serum vitamin D status was an important modifier in the relationship between PA and sarcopenia. As shown in our results, participants with low PA had higher odds of sarcopenia and sarcopenic obesity when participants had vitamin D deficiency. However, low PA was not significantly associated with sarcopenia and sarcopenic obesity among participants with higher concentration of vitamin D (25(OH)D ≥ 20 ng/ml). Another cross-sectional study conducted by Yang et al. found that vitamin D and PA had an interactive effect on sarcopenia.

The effects of vitamin D on sarcopenia may be affected by the level of PA, and the effects of PA may also be affected by vitamin D levels [14]. Yang et al. also found that activity limitation reduced the muscle fiber cross-sectional area and muscle weight in mice, and vitamin D deficiency accelerated the decrease in muscle weight, muscle fiber CSA, and grip strength. In addition, vitamin D supplementation may inhibit the grip strength reduction induced by limited activity [14].

These results may explain the controversial effects of vitamin D or exercise training on muscle mass and muscle function in clinical trials. The results of vitamin D supplementation or exercise therapy may be affected by differences in baseline PA levels and serum 25(OH)D levels in older adults. These findings indicated that participants with inactivity were important population to screen serum vitamin D status. And for them, maintaining sufficient vitamin D may reduce the risk of developing sarcopenia and sarcopenic obesity.

Our study had some strengths. First, WCHAT is a relatively large population-based study, and complete information on physical and health conditions was collected through standardized and structured interviews. Second, diagnosis of sarcopenia was based on the AWGS 2019 consensus, and definition of obesity was based on the combination of BMI and fat mass percentage assessed by BIA, which were more accurate and standard. However, several limitations should be considered in our current study when interpreting the results. First, cross-sectional analyses cannot elucidate any determination of the temporal nature of the associations between variables, for which longitudinal studies are required.

Second, PA evaluation was based on self-reporting not accelerometer-measured physical activities, so potential recall bias may exist. Finally, our study population were from multiple ethnic groups. Although we adjusted for ethnicity in the regression models, the differences in vitamin D levels and PA habits between ethnic groups and whether these differences influence the relationships of them are not clear.

This study has several implications for prevention and intervention to sarcopenia in older people. Firstly, it is recommended that simultaneous screening for vitamin D levels and evaluating levels of PA in older adults. Older adults should strive to avoid both physical inactivity and vitamin D deficiency. Secondly, supplementing vitamin D may help reduce the risk of sarcopenia in individuals with physical inactivity or physical limitations. Thirdly, women are encouraged to increase PA, while men should maintain adequate vitamin D levels.

In the future clinical trials for sarcopenia, the intervention strategies for men and women should be different or individualized.

Conclusion

The role of vitamin D and PA in sarcopenia was different between men and women, and the relationship between PA and sarcopenia modified by serum vitamin D status. These findings highlighted the need to supplement vitamin D in individuals with physical inactivity and provide different interventions strategies to sarcopenia in men and women.

Supplementary Information

Additional file 1: Table S1. Associations between physical activity, vitamin D and obesity/sarcopenia according to age group. Table S2. Vitamin D levels of the total sample and according to physical activity level.

Supplement file at the original source: open the original paper. This file is not included in this text import.

Abbreviations

AWGS

Asian Working Group for Sarcopenia

ASMI

Appendicular skeletal muscle mass index

ADL

Activities of daily living

BMI

Body mass index

BIA

Bioelectrical impedance analysis

CLTPAQ

China Leisure Time Physical Activity Questionnaire

COPD

Chronic obstructive pulmonary diseases

CI

Confidence interval

MLTPAQ

Minnesota Leisure Time Physical Activity Questionnaire

MNA-SF

Mini Nutrition Assessment-Short form

OR

Odds ratio

PA

Physical activity

SD

Standard deviations

SPPB

Short Physical Performance Battery

SMI

Skeletal muscle mass index

SO

Sarcopenic obesity

WCHAT

West China Health and Aging Trend

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Shuli Jia and Wanyu Zhao contributed equally to this work and should be considered co-first authors.

Acknowledgements

We would like to thank all study participants and their families for their cooperation in the research team. The authors also would like to express their gratitude to all the investigators for their time and cooperation during the fieldwork process.

Authors’ contributions

SLJ, WYZ, and BRD designed research; SLJ, WYZ, FJH, YLZ, MLG, JRY and XX conducted research; SLJ analyzed data; and SLJ and WYZ wrote the paper. SLJ had primary responsibility for final content. All authors read and approved the final manuscript.

Funding

This work was supported by the National Key R&D Program of China (2018YFC2000305, 2020YFC2005600, 2020YFC2005602 and 2020YFC0840101); 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYGD20010 and ZY2017201); Geriatric Health Care and Medical Research Center, Sichuan University, Chengdu, Sichuan Province, China; Chengdu Science and Technology Bureau Major Science and Technology Application Demonstration Project (2019YF0900083SN). The financial sponsors had no role in the design, implementation, analyses, or reporting of the results.

Availability of data and materials

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of West China Hospital, Sichuan University (reference: 2017 − 445) and conducted in accordance with the Declaration of Helsinki. This study was registered at the China Clinical Trial Center (Registration Number: ChiCTR1800018895). All participants signed the informed consent before participating.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interest.

References

1. Cruz-Jentoft AJ Sayer AA Sarcopenia Lancet 2019 393 10191 2636 2646 10.1016/S0140-6736(19)31138-9 31171417
2. Batsis JA Villareal DT Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies Nat Rev Endocrinol 2018 14 9 513 537 10.1038/s41574-018-0062-9 30065268 PMC6241236
3. Kokkeler KJE van den Berg KS Comijs HC Oude Voshaar RC Marijnissen RM Sarcopenic obesity predicts nonremission of late-life depression Int J Geriatr Psychiatry 2019 34 8 1226 1234 10.1002/gps.5121 30990918
4. Shaw SC Dennison EM Cooper C Epidemiology of sarcopenia: determinants throughout the lifecourse Calcif Tissue Int 2017 101 3 229 247 10.1007/s00223-017-0277-0 28421264 PMC5544114
5. Lips P Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications Endocr Rev 2001 22 4 477 501 10.1210/edrv.22.4.0437 11493580
6. Remelli F Vitali A Zurlo A Volpato S Vitamin D deficiency and sarcopenia in older persons Nutrients 2019 11 12 2861 10.3390/nu11122861 31766576 PMC6950416
7. Houston DK Tooze JA Hausman DB Johnson MA Nicklas BJ Miller ME Change in 25-hydroxyvitamin D and physical performance in older adults J Gerontol A Biol Sci Med Sci 2011 66 4 430 436 10.1093/gerona/glq235 21325343 PMC3055282
8. Granic A Hill TR Davies K Jagger C Adamson A Siervo M Vitamin D status, muscle strength and physical performance decline in very old adults: a prospective study Nutrients 2017 9 4 379 10.3390/nu9040379 28406464 PMC5409718
9. Gallagher JC Yalamanchili V Smith LM The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women J Steroid Biochem Mol Biol 2013 136 195 200 10.1016/j.jsbmb.2012.12.003 23246640 PMC3686842
10. Karampela I Sakelliou A Vallianou N Christodoulatos GS Magkos F Dalamaga M Vitamin D and obesity: current evidence and controversies Curr Obes Rep 2021 10 2 162 180 10.1007/s13679-021-00433-1 33792853
11. Park S Ham JO Lee BK A positive association of vitamin D deficiency and sarcopenia in 50 year old women, but not men Clin Nutr 2014 33 5 900 905 10.1016/j.clnu.2013.09.016 24140234
12. Spira D Buchmann N König M Rosada A Steinhagen-Thiessen E Demuth I Sex-specific differences in the association of vitamin D with low lean mass and frailty: results from the Berlin Aging Study II Nutrition 2019 62 1 6 10.1016/j.nut.2018.11.020 30822744
13. Tabrizi R Hallajzadeh J Mirhosseini N Lankarani KB Maharlouei N Akbari M The effects of vitamin D supplementation on muscle function among postmenopausal women: a systematic review and meta-analysis of randomized controlled trials Excli j 2019 18 591 603 31611742 10.17179/excli2019-1386 PMC6785780
14. Yang A Lv Q Chen F Wang Y Liu Y Shi W The effect of vitamin D on sarcopenia depends on the level of physical activity in older adults J Cachexia Sarcopenia Muscle 2020 11 3 678 689 10.1002/jcsm.12545 32020783 PMC7296263
15. Beaudart C Buckinx F Rabenda V Gillain S Cavalier E Slomian J The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials J Clin Endocrinol Metab 2014 99 11 4336 4345 10.1210/jc.2014-1742 25033068
16. Lee SY Tung HH Liu CY Chen LK Physical activity and sarcopenia in the geriatric population: a systematic review J Am Med Dir Assoc 2018 19 5 378 383 10.1016/j.jamda.2018.02.003 29580886
17. Lu L Mao L Feng Y Ainsworth BE Liu Y Chen N Effects of different exercise training modes on muscle strength and physical performance in older people with sarcopenia: a systematic review and meta-analysis BMC Geriatr 2021 21 1 708 10.1186/s12877-021-02642-8 34911483 PMC8672633
18. Cheng SH Chen KH Chen C Chu WC Kang YN The optimal strategy of vitamin D for sarcopenia: a network meta-analysis of randomized controlled trials Nutrients 2021 13 10 3589 10.3390/nu13103589 34684590 PMC8541573
19. Hou L Liu X Zhang Y Zhao W Xia X Chen X Cohort profile: West China Health and Aging Trend (WCHAT) J Nutr Health Aging 2021 25 3 302 310 10.1007/s12603-020-1530-1 33575720
20. Zhou BF Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults Biomed Environ Sci 2002 15 1 83 96 12046553
21. Chen LK Woo J Assantachai P Auyeung TW Chou MY Iijima K Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment J Am Med Dir Assoc 2020 21 3 300 7.e2 10.1016/j.jamda.2019.12.012 32033882
22. Wang Y Deng C Ding D Song Y Lin T Yue J Development and validation of the China leisure time physical activity questionnaire in the elderly Practical Geriatrics 2019 33 3 229 233
23. Taylor HL Jacobs DR Jr Schucker B Knudsen J Leon AS Debacker G A questionnaire for the assessment of leisure time physical activities J Chronic Dis 1978 31 12 741 755 10.1016/0021-9681(78)90058-9 748370
24. Ainsworth BE Haskell WL Herrmann SD Meckes N Bassett DR Jr Tudor-Locke C 2011 Compendium of physical activities: a second update of codes and MET values Med Sci Sports Exerc 2011 43 8 1575 1581 10.1249/MSS.0b013e31821ece12 21681120
25. Mahoney FI Barthel DW Functional evaluation: the Barthel Index Md State Med J 1965 14 61 65 14258950
26. Kaiser MJ Bauer JM Ramsch C Uter W Guigoz Y Cederholm T Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status J Nutr Health Aging 2009 13 9 782 788 10.1007/s12603-009-0214-7 19812868
27. Gao Q Hu K Yan C Zhao B Mei F Chen F Associated factors of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis Nutrients 2021 13 12 4291 10.3390/nu13124291 34959843 PMC8707132
28. Scott D Johansson J Gandham A Ebeling PR Nordstrom P Nordstrom A Associations of accelerometer-determined physical activity and sedentary behavior with sarcopenia and incident falls over 12 months in community-dwelling Swedish older adults J Sport Health Sci 2021 10 5 577 584 10.1016/j.jshs.2020.01.006 34088651 PMC8500807
29. Volpi E Nazemi R Fujita S Muscle tissue changes with aging Curr Opin Clin Nutr Metab Care 2004 7 4 405 410 10.1097/01.mco.0000134362.76653.b2 15192443 PMC2804956
30. Vimaleswaran KS Berry DJ Lu C Tikkanen E Pilz S Hiraki LT Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts PLoS Med 2013 10 2 e1001383 10.1371/journal.pmed.1001383 23393431 PMC3564800
31. Wortsman J Matsuoka LY Chen TC Lu Z Holick MF Decreased bioavailability of vitamin D in obesity Am J Clin Nutr 2000 72 3 690 693 10.1093/ajcn/72.3.690 10966885
32. Ko YC Chie WC Wu TY Ho CY Yu WR A cross-sectional study about the relationship between physical activity and sarcopenia in Taiwanese older adults Sci Rep 2021 11 1 11488 10.1038/s41598-021-90869-1 34075104 PMC8169879
33. Steffl M Bohannon RW Sontakova L Tufano JJ Shiells K Holmerova I Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis Clin Interv Aging 2017 12 835 845 10.2147/CIA.S132940 28553092 PMC5441519
Publication and source details

Original title: Sex differences in the association of physical activity levels and vitamin D with obesity, sarcopenia, and sarcopenic obesity: a cross-sectional study

Shuli Jia; Wanyu Zhao; Fengjuan Hu; Yunli Zhao; Meiling Ge; Xin Xia; Jirong Yue; Birong Dong

BMC Geriatrics · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.the National Key R&D Program of China2018YFC2000305, 2020YFC2005600, 2020YFC2005602 and 2020YFC08401012018YFC2000305, 2020YFC2005600, 2020YFC2005602 and 2020YFC08401011.3.5 project for disciplines of excellence, West China Hospital, Sichuan UniversityZYGD20010 and ZY2017201ZYGD20010 and ZY2017201Geriatric Health Care and Medical Research Center, Sichuan University, Chengdu, Sichuan Province, ChinaChengdu Science and Technology Bureau Major Science and Technology Application Demonstration Project2019YF0900083SN2019YF0900083SN

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:49:22.868514+00:00

DOI: 10.1186/s12877-022-03577-4 · PMC9701059